T-cell subsets in schizophrenia: A comparison between drug-naive first episode patients and chronic schizophrenic patients

Schizophrenia Research

Volumn 38, Issue 1, 1999, Pages 61-70

  Sperner Unterweger, Barbara ^a   Whitworth, Alexandra ^a   Kemmler, Georg ^a   Hilbe, Wolfgang ^b   Thaler, Josef ^b   Weiss, Günter ^b   Fleischhacker, W Wolfgang ^b  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Cytokine; Immunology; Psychopathology; Schizophrenia; T cell subset

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CYTOKINE; NEUROLEPTIC AGENT;

ACUTE DISEASE; ADULT; ARTICLE; CHRONIC DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; SUPPRESSOR CELL; SYMPTOMATOLOGY; T LYMPHOCYTE SUBPOPULATION;

ACUTE DISEASE; ADULT; ANTIPSYCHOTIC AGENTS; CD4-CD8 RATIO; CHRONIC DISEASE; CYTOKINES; FEMALE; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; SCHIZOPHRENIA; T-LYMPHOCYTE SUBSETS;

EID: 0033609544     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(98)00175-3     Document Type: Article

References (50)

1. Abdeljaber M.H., Nair M.P.N., Schork M.A., Schwartz S.A. Depressed natural killer cell activity in schizophrenic patients. Immun. Investigations. 23:1994;259-268.
2. Achiron A., Noy S., Lereya J., Hermesh H., Laor N., Pras E. T-cell subsets in acute psychotic schizophrenic patients. Soc. Biol. Psychiatry. 35:1994;27-31.
3. Bessler H., Eviatar J., Meshulam M., Tyano S., Djaldetti M., Sirota P. Theophylline-sensitive T-lymphocyte subpopulation in schizophrenic patients. Biol. Psychiatry. 22:1987;1025.
4. Bessler H., Levental Z., Karp L., Modai I., Djaldetti M., Weizman A. Cytokine production in drug-free and neuroleptic-treated schizophrenic patients. Biol. Psychiatry. 38:1995;297-302.
5. Caldwell C.L., Irwin M., Lohr J. Reduced naturel killer cell cytotoxicity in depression but not in schizophrenia. Biol. Psychiatry. 30:1991;1131-1138.
6. Coffey C.E., Sullivan J.L., Rice J.R. T lymphocytes in schizophrenia. Biol. Psychiatry. 18:1983;113-119.
7. Crow T.J. A re-evaluation of the viral hypothesis: is psychosis the result of retroviral integration at a site close to the cerebral dominance gene? Br. J. Psychiatry. 145:1984;243-253.
8. DeLisi L.E., Crow T.J. Is schizophrenia a viral or immunologic disorder? Psychiatry Clin. North Am. 9:1986;115-132.
9. DeLisi L.E., Goodman S., Neckers L.M., Wyatt R.J. An analysis of lymphocyte subpopulations in schizophrenic patients. Biol. Psychiatry. 17:1982;1003-1009.
10. DeLisi L.J., Ortaldo A., Maluih A. Deficient natural killer cell (NK) activity and macrophage functioning in schizophrenic patients. J. Neural. Transm. 58:1983;96.
11. Drovakova M., Zvolsky P., Herzog P. Endogenous psychoses and T and B lymphocytes. Folia Haematol. (Leipz). 107:1980;221-228.
12. Ganguli, R., Rabin, B.S., Raghu, U., Ulrich, R., 1987. T lymphocytes in schizophrenics and normals and the effects of varying antipsychotic dosage. In: Kurstak, L.M. (Ed.), Viruses, Immunity, and Mental Disorders. Plenum Medical, New York.
13. Ganguli R., Brar J.S., Solomon W., Chengappa K.N.R., Rabin B.S. Altered interleukin-2 production in schizophrenia. Psychiatry Res. 44:1992;113-123.
14. Ganguli R., Brar J.S., Chengappa K.M.R., Yang Z.W., Nimgaonkar V.L., Rabin B.S. Autoimmunity in schizophrenia: a review of recent findings. Ann. Med. 25:1993;489-496.
15. Ganguli R., Brar J.S., Rabin B.S. Immune abnormalities in schizophrenia: evidence for the autoimmune hypothesis. Harvard Rev. Psychiatry. 2:1994;70-83.
16. Goodall E. The existing cause of certain states, at present classified under 'schizophrenia' by psychiatrists may be infection. J. Ment. Sci. 78:1932;746.
17. Henneberg A., Riedl B., Dumke H.O., Kornhuber H.H. T-lymphocyte subpopulations in schizophrenic patients. Eur. Arch. Psychiatr. Neurol. Sci. 239:1990;283-284.
18. Hornberg M., Arolt V., Wilke I., Kruse A., Kirchner H. Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia. Schizophr. Res. 15:1995;237-242.
19. Katila H., Cantell K., Hirronen S., Rimon R. Production of interferon-alpha and -gamma by leukocytes from patients with schizophrenia. Schizophr. Res. 2:1989;361-365.
20. Kirch D.G. Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal. Schizophr. Bull. 19:1993;355-370.
21. Knight J. Possible autoimmune mechanisms in schizophrenia. Integr. Psychiatry. 3:1985;134.
22. Kotylo, P.K., 1991. Reference ranges for lymphocyte subsets. Arch. Pathol. Lab. Med. 115.
23. Lowder, W., 1989. Normalwerte der Lymphozytensubsets. Hematological Meeting Genf.
24. Masserini C., Vita A., Basile R., Morselli R., Boato P., Peruzzi C. Lymphocyte subsets in schizophrenic disorders: relationship with clinical, neuro-morphological and treatment variables. Schizophr. Res. 3:1990;269-275.
25. McDaniel J.S., Jewart R.D., Eccard M.B., Pollard W.E., Caudle J., Stipetic M., Risby E.D., Lewine R., Risch C. Schizophr. Res. 8:1992;125-128.
26. Menninger K. The schizophrenic syndrome as a product of acute infectious disease. Arch. Neurol. Psychiatry. 20:1928;464.
27. Moises H., Schindler L., Leroux M., Kirchner H. Decreased production of interferon alpha and interferon gamma in leucocyte cultures of schizophrenic patients. Acta Psychiat. Scand. 72:1985;45.
28. Müller N., Ackenheil M., Hofschuster E., Eckstein R., Mempel W. Cellular immunity in schizophrenic patients before and during neuroleptic treatment. Psychiatry Res. 37:1991;147-160.
29. Müller N., Hofschuster E., Ackenheil M., Eckstein R. T-cells and psychopathology in schizophrenia: relationship to the outcome of neuroleptic therapy. Acta Psychiatr. Scand. 87:1993;66-71.
30. Nyland H., Naess A., Lunde H. Lymphocyte subpopulations in peripheral blood from schizophrenic patients. Acta Psychiatr. Scand. 61:1980;313-318.
31. Parker D.C. T cell-dependent B cell activation. Ann. Rev. Immunol. 46:1993;111-147.
32. Pulver A.E., Kung-Lee Y., Wolniec P.S. Season of birth of siblings of schizophrenic patients. Br. J. Psychiatry. 160:1992;71-75.
33. Rabin B.S., Ganguli R., Cunnick J.E., Lysle D.T. The central nervous system-immune system relationship. Clin. Lab. Med. 8:1988;253-268.
34. Rogozhnikova O.A. Status of the T-lymphocyte system of immunity in patients with newly diagnosed paroxysmal schizophrenia. Zh. Nevropatol. Psikhiatr. 91:1991;47-49.
35. Romagnani S., Del Prete G., Manetti R., Ravina A., Annunziato F., Delarli M., Mazzetti M., Piccinni M.P., D'Elios M.M., Parronchi P. Role of TH1/TH2 cytokines in HIV infection. Immunol. Rev. 140:1994;73-92.
36. Rothermundt M., Arolt V., Weitzsch C., Eckhoff D., Kirchner H. Production of cytokines in acute schizophrenic psychosis. Biol. Psychiatry. 40:1996;1294-1297.
37. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology. 1:1990;43-46.
38. Saifulina N.A., Arkhipov G.S., Stepanov A.F., Gusev I. T- and B-lymphocytes and their clinico-pathogenetic significance in patients with paranoid schizophrenia. Zh. Nevropatol. Psikhiatr. 90:1990;87-90.
39. Schindler L., Leroux M., Beck J., Moises H.W., Kirchner H. Studies of cellular immunity, serum interferon titers and of natural killer cell activity in schizophrenic patients. Acta Psychiatr. Scand. 72:1985;45.
40. Schindler L., Leroux M., Beck J., Moises H.W., Kirchner H. Studies of cellular immunity, serum interferon titers, and natural killer cell activity in schizophrenic patients. Acta Psychiat. Scand. 73:1986;61.
41. Sperner-Unterweger B., Barnas C., Fleischhacker W.W., Fuchs D., Meise U., Reibnegger G., Wachter H. Is schizophrenia linked to alteration in cellular immunity? Schizophr. Res. 2:1989;417-421.
42. Sperner-Unterweger B., Barnas C., Fuchs D., Kemmler G., Wachter H., Hinterhuber H., Fleischhacker W.W. Neopterin production in acute schizophrenic patients: an indicator of alterations of cell-mediated immunity. Psychiatry Res. 42:1992;121-128.
43. Torrey E., Torrey B., Petersen M. Seasonality of schizophrenic births in the United States. Arch. Gen. Psychiatry. 34:1977;1065.
44. Tsukasa S., Shinichiro N., Rimmei F., Tsuneta K., Hiroshi K., Hajime K. Changes of immunological functions after acute exacerbation in schizophrenia. Biol. Psychiatry. 35:1994;173-178.
45. Vartanian M.E., Koliaskina G.I., Lozovsky D.V., Burbaeva G.S., Ignatov S.A. Aspects of humoral and cellular immunity in schizophrenia. Birth Defects. 14:1978;339-364.
46. Vieweg V., Levinson J., Pendurangi A. Medical disorders in the schizophrenic patient. Int. J. Psychiatry Med. 25(2):1995;137-172.
47. Villemain F., Chatenoud L., Galinowski A., Homo-Delarche F., Ginstet D., Loo H., Zarifian E., Bach J.F. Aberrant T-cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2-production. Am. J. Psychiatry. 146:1989;609.
48. Watson S., Kucala T., Tilleskjor C. Schizophrenic births seasonality in relation to the incidence of infectious diseases and temperature extremes. Arch. Gen. Psychiatry. 41:1984;85.
49. Webster E.L., Torpy D.J., Elenkov I.J., Chrousos G.P. Corticotropin-releasing hormone and inflammation. Ann. N.Y. Acad. Sci. 840:1998;21-32.
50. Zarrabi M.H., Zucker S., Miller T., Derman R.M., Romeno G.S., Hartnett J.A. Immunological and coagulation disorders in chlorpromazine-treated patients. Ann. Intern. Med. 91:1979;194-199.